YJP-14 Capsules

· Han Wha Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YJP-14 Capsules, covering 2016-08-17 to 2016-08-17. Get the full timeline:

Most recent: Clinical Trial Update: YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus [Phase 2]